STAT

‘We didn’t follow through’: He wrote the Ebola ‘lessons learned’ report for Obama. Now he weighs in on coronavirus response

“We’re not ideally positioned to respond" to the #coronavirus, says the official who wrote the government's report on lessons learned from Ebola.
A view of gloves and boots used by medical staff, drying in the sun, at a center for victims of the Ebola virus in Guekedou.

Christopher Kirchhoff knows how to assess the U.S. government’s response to a public health crisis.

Kirchhoff, an aide at the Pentagon who moved to the White House during the height of the West African Ebola outbreak, was tapped to write a 2016 report about the lessons the U.S. could learn from the epidemic — and the steps it could take to prepare for the next outbreak of an emerging infection.

“It was through that experience that I think we all came to realize that it’s not just Ebola, but actually there’s a number of pathogens that could be super dangerous to our security,” Kirchhoff said.

STAT on Monday spoke with Kirchhoff, a political scientist by training, about what he learned from compiling the Ebola report and what he thought of the U.S. response to Covid-19. Kirchhoff — now , a philanthropic organization — spoke carefully, often pausing for several seconds before answering and continuing

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks